Emergent BioSolutions (EBS) 2025 Conference June 05, 2025 01:25 PM ET Speaker0 Okay. Speaker1 Good afternoon, and welcome to the Jefferies Global Healthcare Conference. My name is Victoria Gendron with the Jefferies Investment Banking Team, and it is with my great pleasure to introduce Richard Lindahl, the CFO of Emergent BioSolutions. Speaker0 Okay. Thank you very much, Victoria, and, thank you all for coming today. We appreciate your interest in our company. I'm going to start, with the standard safe harb ...

Day在最新研判中指出，黄金市场正迎来多重基本面支撑：全球央行购金步伐持续加速，地缘政治不确 定性推升避险需求，同时主要经济体财政可持续性担忧不断发酵。经济合作与发展组织（OECD）本周 将2024年全球经济增长预期大幅下调至1.6%，直指美国贸易保护主义政策对全球贸易体系的冲击。该 预期修正直接导致美元指数承压，为金价连续第三周上涨奠定基础。 国际贵金属市场持续走强，现货黄金价格稳守2350美元/盎司关口，白银价格突破34美元/盎司，创2012 年以来新高。知名投资管理人Adrian Day近日警示，当前市场对矿业企业的估值存在显著偏差，且全球 金融体系正面临潜在流动性危机，这或将迫使美联储于三季度重启量化宽松政策。 值得关注的是，Day提出美国财政部或将在三季度面临资金枯竭风险。他分析认为，当财政融资压力突 破临界点时，美联储将被迫通过扩大资产负债表提供流动性支持。"相较于单纯降息，重启量化宽松的 概率显著更高，市场关注焦点已从就业市场转向政府偿债能力。"这一判断与此前主流预期存在明显分 歧。 在资产配置层面，Day强调矿业板块存在显著价值洼地。以Agnico Eagle Mines为例，尽管当前利润率处 ...

Cooper Standard, headquartered in Northville, Mich., with locations in 20 countries, is a leading global supplier of sealing and fluid handling systems and components. Utilizing our materials science and manufacturing expertise, we create innovative and sustainable engineered solutions for diverse transportation and industrial markets. Cooper Standard's approximately 22,000 team members (including contingent workers) are at the heart of our success, continuously improving our business and surrounding commun ...

PASADENA, Calif., May 27, 2025 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative Megacampus™ ecosystems in AAA life science innovation cluster locations, continues to leverage its leadership position at the vanguard of the life science ecosystem to forge and strengthen strategic partnerships aimed at speeding and improving patient outcomes amid the nation's complex mental health crisis. As M ...

Core Insights - Tesla's sales in Europe have plummeted by 49% last month, despite a 28% increase in overall battery electric vehicle sales in the region [1][4] - The refreshed Model Y has not improved sales performance, indicating ongoing brand challenges for Tesla [2] - Elon Musk's political affiliations and comments have contributed to a brand crisis, impacting sales and leading to protests against the company [3] Sales Performance - Tesla's sales decline is significant compared to competitors, with BMW, Renault, and VW experiencing sales growth, and VW surpassing Tesla as the largest EV seller in Europe [4] - Chinese competitors, such as SAIC Motor and BYD, have reported strong sales increases, with BYD outselling Tesla in Europe for the first time last month [5] Market Context - The overall market for battery electric vehicles in Europe is growing, yet Tesla is struggling to maintain its market position [1][4] - Musk's assertion that Tesla is not facing demand issues contrasts with the evident sales decline, suggesting a disconnect between company leadership and market realities [3]

Group 1: Michael Burry's Investment Actions - Michael Burry sold off his entire investment portfolio in Q1, except for Estee Lauder, in which he doubled his position [2] - He bought put options on Nvidia and several Chinese ADRs, indicating a bearish outlook on these stocks [3] - Burry's actions suggest a strategic pivot, betting against the U.S. and Chinese markets while maintaining confidence in Estee Lauder [4] Group 2: Estee Lauder's Business Overview - Estee Lauder is a global beauty conglomerate with a portfolio of luxury brands, including Clinique, MAC, and La Mer [5] - The company has faced challenges due to its exposure to China and the duty-free shopping market, with sales in China recovering slowly post-COVID [6][7] - Increased competition from newer prestige beauty brands has also impacted Estee Lauder's market position in the U.S. [9] Group 3: Financial Performance and Strategy - Estee Lauder's sales declined by 10% and adjusted operating income fell by 27% last quarter, with retail travel revenue dropping 28% [14] - The company is implementing a profit recovery and growth plan, which includes cost reductions and layoffs to restore sales growth and improve margins [13] - Despite current challenges, if the company can regain lost earnings, there could be significant upside potential for its stock [15][16]

Group 1 - The focus has shifted towards offshore drilling, supply industry, and shipping, including tankers, containers, and dry bulk [1] - The fuel cell industry is being monitored as it is still in its early stages of development [1] Group 2 - The individual has extensive experience in auditing with PricewaterhouseCoopers before transitioning to day trading nearly 20 years ago [2] - Successfully navigated significant market events such as the dotcom bubble, the aftermath of the World Trade Center attacks, and the subprime crisis [2]

今年4月，美国面向世界各国推出所谓的"对等关税"政策，扰动全球金融市场，欧元却逆势升值。近期，欧盟及欧洲央行密集表态，提升欧元储备货币地位 的呼声再起。 "许多尚未使用欧元的欧盟国家，会意识到加入欧元区是更好的选择。"马克·乌赞表示。 欧元区或再次扩张 所谓储备货币，是各国用作外汇储备的货币，具备可自由兑换、广泛用于国际结算的特点。一战前的英镑、二战后的美元均担任过这一角色。 自4月2日美国公布所谓"对等关税"后，欧元却在整个四月份逆势走强。尽管欧洲央行同期还宣布降息，欧元兑美元一度录得6.5%的区间涨幅。 21世纪经济报道记者 黄子潇 深圳报道 欧洲人正在经历一场身份认同危机。 曾以和平、繁荣、多边主义为标签的欧洲，如今正在谋求更多的战略自主权。 "很难想象，我们（欧洲）不再利用和平的红利，却在考虑不同的支出——我们必须再次把钱花在国防上，而不是花在脱碳和气候上。"2025清华五道口全球 金融论坛期间，法国著名经济学家马克·乌赞接受了21世纪经济报道记者的采访。 马克·乌赞（Marc Uzan）是重塑布雷顿森林委员会（Reinventing Bretton Woods Committee）的执行董事兼创始人 ...

Debt-at-Risk Davide Furceri, Domenico Giannone, Faizaan Kisat, W. Raphael Lam, and Hongchi Li WP/25/86 IMF Working Papers describe research in progress by the author(s) and are published to elicit comments and to encourage debate. The views expressed in IMF Working Papers are those of the author(s) and do not necessarily represent the views of the IMF, its Executive Board, or IMF management. 2025 MAY © 2025 International Monetary Fund WP/25/86 IMF Working Paper Fiscal Affairs Department Debt-at-Risk Prepare ...

Acadia Healthcare Company (ACHC) 2025 Conference Summary Industry Overview - Acadia Healthcare is one of the largest behavioral health providers in the US, operating a network of 270 facilities with approximately 12,000 beds across 39 states and Puerto Rico, serving over 80,000 patients daily [6][7][8]. Key Financial Performance - The company reported that revenue, EBITDA, volume, revenue per day, and margins were all in line with guidance, with EBITDA at the high end of the range [2][3]. - Acadia added 378 newly licensed beds in Q1 and reaffirmed its full-year financial guidance for both revenue and adjusted EBITDA [3][4]. Demand and Growth Outlook - Consistent demand is observed across all four lines of business, with a significant opportunity in the behavioral health sector due to an estimated 75,000 additional beds needed in the US to meet demand [6][7]. - The company is in a period of record growth, expecting to add 800 to 1,000 beds in 2025, with nearly half already achieved in Q1 [10][11]. - The Comprehensive Treatment Centers (CTCs) segment is expected to grow mid-single digits over the next few years, with a strong demand for opioid use disorder treatment [9][15]. Operational Insights - The average cost per new facility bed is estimated at $500,000 to $550,000, with a target breakeven period of 12 to 13 months and expected maturity occupancy of 80% to 85% within three to five years [12][13]. - The company is focused on tuck-in M&A to acquire existing CTCs, which is a fragmented part of healthcare, enhancing growth and efficiency [18]. Policy and Regulatory Environment - Acadia is monitoring the implications of the opioid settlement funds, with $50 billion available but only a small percentage reaching states and counties [19][20]. - The company is optimistic about the potential impact of the reconciliation bill on access to high acuity mental health care, which could mitigate costs in other healthcare areas [24][25]. Pricing and Revenue Guidance - The company anticipates low single-digit pricing growth, with supplemental payments being a significant factor in revenue projections [46][47]. - For 2025, Acadia expects revenue growth of 6%, but EBITDA is projected to decline year-over-year due to various headwinds, including supplemental payment reductions and underperforming facilities [52][53]. Challenges and Risks - The company faces challenges from underperforming facilities, which are expected to impact EBITDA by approximately $20 million for the year [34][38]. - There is ongoing concern regarding potential policy changes and their impact on Medicaid access and reimbursement rates [26][30]. Conclusion - Acadia Healthcare is positioned for growth in the behavioral health sector, with strong demand and strategic plans for bed additions and acquisitions. However, it must navigate regulatory challenges and operational headwinds to achieve its financial targets [41][44].